Skip to main content
. 2019 Nov 11;9(63):36608–36614. doi: 10.1039/c9ra06088j

Bioreductions on preparative scalea.

Substrate Enzyme (mg mL−1) Product Isolated yield (%) d.r.
graphic file with name c9ra06088j-u4.jpg pQR1445 (0.5) graphic file with name c9ra06088j-u5.jpg 95b 98 : 2
graphic file with name c9ra06088j-u6.jpg pQR1907 (1) graphic file with name c9ra06088j-u7.jpg 95b Syn only
graphic file with name c9ra06088j-u8.jpg pQR1907 (2) graphic file with name c9ra06088j-u9.jpg 71b,c Syn only
graphic file with name c9ra06088j-u10.jpg pQR1907 (2) graphic file with name c9ra06088j-u11.jpg 90d 58 : 42
graphic file with name c9ra06088j-u12.jpg pQR1907 (2) graphic file with name c9ra06088j-u13.jpg 90d 85 : 15
graphic file with name c9ra06088j-u14.jpg pQR1907 (1) graphic file with name c9ra06088j-u15.jpg 94b Syn only
graphic file with name c9ra06088j-u16.jpg pQR1907 (4) graphic file with name c9ra06088j-u17.jpg 50d
a

Substrate (5 mM for rac-16; 10 mM for S-5 and R-11 20 mM for S-8, S-11, rac-11, S-14), co-expressed ER/G6PDH (1–4 mg mL−1), NADP+ (2.8 mM), G6PNa (100 mM), in Tris–HCl (50 mM) and DMSO (10%) at pH = 7.4, 30 °C, 300 rpm.

b

Isolated yield.

c

Purification by column chromatography.

d

2.5 mL scale. Quantification by NMR using an internal standard (1,3,5-trimethoxybenzene).